Evidence map›Paper›PMID 39806118›Full record

ArticleMedical & biological engineering & computing2025

Toward efficient slide-level grading of liver biopsy via explainable deep learning framework.

Bingchen Li, Qiming He, Jing Chang, Bo Yang, Xi Tang, Yonghong He, Tian Guan, Guangde Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bingchen Li *Shenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, 518000, China.ORCID http://orcid.org/0000-0003-0586-9760
Qiming He *Shenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, 518000, China.
Jing Chang *Pathology Department, Beijing Youan Hospital, Capital Medical University, Beijing, 100000, China.
Bo YangShenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, 518000, China.
Xi TangShenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, 518000, China.
Yonghong HeShenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, 518000, China.
Tian GuanShenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, 518000, China. guantian@sz.tsinghua.edu.cn.
Guangde ZhouPathology Department, Beijing Youan Hospital, Capital Medical University, Beijing, 100000, China. guangdez@sina.com.

Funding

Science and Technology Foundation of Shenzhen City KCXFZ202012211173207022
6 · The paper itself

Abstract

In the context of chronic liver diseases, where variability in progression necessitates early and precise diagnosis, this study addresses the limitations of traditional histological analysis and the shortcomings of existing deep learning approaches. A novel patch-level classification model employing multi-scale feature extraction and fusion was developed to enhance the grading accuracy and interpretability of liver biopsies, analyzing 1322 cases across various staining methods. The study also introduces a slide-level aggregation framework, comparing different diagnostic models, to efficiently integrate local histological information. Results from extensive validation show that the slide-level model consistently achieved high F1 scores, notably 0.9 for inflammatory activity and steatosis, and demonstrated rapid diagnostic capabilities with less than one minute per slide on average. The patch-level model also performed well, with an F1 score of 0.64 for ballooning and 0.99 for other indicators, and proved transferable to public datasets. The conclusion drawn is that the proposed analytical framework offers a reliable basis for the diagnosis and treatment of chronic liver diseases, with the added benefit of robust interpretability, suggesting its practical utility in clinical settings.

Indexed as

Deep LearningLiverLiver DiseasesBiopsyHumansChronic liver diseasesDeep learningHistological diagnosisLiver biopsy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.